Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)

China flag China · Delayed Price · Currency is CNY
16.32
+0.62 (3.95%)
Jun 23, 2026, 3:00 PM CST
Market Cap2.63B -41.2%
Revenue (ttm)1.30B +3.8%
Net Income11.06M -92.4%
EPS0.07 -92.3%
Shares Out 167.44M
PE Ratio234.92
Forward PE12.71
Dividend0.25 (1.59%)
Ex-Dividend DateJun 3, 2026
Volume4,407,335
Open15.64
Previous Close15.70
Day's Range15.44 - 16.66
52-Week Range15.11 - 40.19
Beta0.49
Analystsn/a
Price Targetn/a
Earnings DateAug 10, 2026

About SHA:688687

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manuf... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 617
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688687
Full Company Profile

Financial Performance

In 2025, SHA:688687's revenue was 1.32 billion, an increase of 7.35% compared to the previous year's 1.23 billion. Earnings were 30.60 million, a decrease of -78.51%.

Financial Statements